Therefore, we hypothesize that targeting the FA/BRCA pathway to inhibit DNA damage repair via inhibition of FANCF is vital for increasing the sensitivity to MX, the topoisomerase II poison in the breast cancer. The gene discussed is FANCA; the disease is breast carcinoma.